Data
Relevant datasets produced at DBMR and other departments with related research. Researchers are encouraged to describe their datasets here, thereby showcasing their current work and creating opportunities for new collaborations.
If you would like to have your data featured here, you can submit it via the link on the left, or feel free to contact us. Prioritise datasets that could be useful for other projects.
| Group | Data type | Species | Cell type | Experimental design | Samples | Public repo | Published | Comment | Contact |
|---|---|---|---|---|---|---|---|---|---|
RNAseq ATACseq ChIPseq PROcap |
Human |
Prostate cancer | SMARCA4 protac vs control, 24h, 48h | 3 reps per group | WCM1078 cell line | Phillip Thienger | |||
| RNA-seq | Human |
Prostate cancer | E2Fs combinatorial KDs | 3 reps per group | NA | no | WCM154 cell line | Phillip Thienger | |
scRNA scATAC |
Mouse |
Prostate cancer | Tracing cancer plasticity and differentiation | 13 | NA | no | Irene Paassen | ||
| Methylation | Mouse |
Prostate cancer | PTEN + RB1 KOs | 2 x 3 reps | NA |
no | MethylationEPIC 285K | Phillip Thienger | |
| WES | Human |
Prostate cancer | Patient cohort landscape | 168 (51 patients) | TMAs from Insel | Andrej Benjak | |||
Methylation |
Human |
Prostate cancer | Patient cohort landscape | 155 (43 patients) | TMAs from Insel; MethylationEPIC 850K | Andrej Benjak | |||
u6atac IHC RNAseq |
Human |
Prostate cancer | Minor intron spliceosome in cancer | 49 | NA |
no |
TMAs from Insel; NanoString; matched tumor and TME regions |
Anke Augspach | |
| RNAseq | Human |
Prostate cancer | siU6atac vs control | 10 x 4rep |
NA |
no |
PacBio + Illumina | Anke Augspach | |
| RNAseq | Human |
Prostate cancer | Minor spliceosome snRNA expression in cancer | 13 cell lines; 3 patients |
NA | no |
total RNA | Anke Augspach | |
| Spatial transcriptomics | Human |
Wilms tumor | Patient cohort landscape |
14 patients, 62 cores |
NA | no | CosMx (6000 genes panel, subcellular resolution). 2 TMAs, 62 cores (diameter: 2mm) from different tumor localizations. |
Larissa Imhof | |
| MRI | Human |
Glioblastoma | Longitudinal glioblastoma cohort from Bern | 91 patients; 638 timepoints; 2,487 MR images | Longitudinal brain MRI: T1 pre/post-contrast, T2, FLAIR; automated tumor segmentations, radiomic features; expert RANO response ratings; selected clinical/pathology variables | Mauricio Reyes; Yannick Suter | |||
| MRI | Human |
Brain metastasis | Multi-center, longitudinal pre- and post-treatment imaging | 75 patients; 637 images; 260 lesions |
Spanish-led international collaboration. MRI with semi-automatic metastasis delineations and related clinical features |
Mauricio Reyes | |||
| MRI | Human |
Brain | multi-center benchmark collection covering sub-acute lesion segmentation, acute perfusion estimation, and stroke lesion outcome prediction |
cohort sizes differ by year |
ISLES 2015–2018 datasets |
Mauricio Reyes | |||
| MRI | Human |
Brain | multi-center benchmark collection covering sub-acute lesion segmentation, acute perfusion estimation, and stroke lesion outcome prediction |
250 |
ISLES 2015–2018 datasets |
Mauricio Reyes | |||
| MRI | Human |
Brain | multi-center benchmark collection covering sub-acute lesion segmentation, acute perfusion estimation, and stroke lesion outcome prediction |
149 | ISLES 2024 dataset |
Mauricio Reyes | |||
| MRI | Human |
Brain | multi-center benchmark collection covering sub-acute lesion segmentation, acute perfusion estimation, and stroke lesion outcome prediction |
1271 (33 cohorts) | Anatomical Tracings of Lesions After Stroke (ATLAS) |
Mauricio Reyes | |||
| RNAseq | Human |
Skin |
Matched non-lesional and lesional skin of positive patch-test reactions to nickel at 24h, 48h, and 120h post-allergen application |
24 | Nicole Bertschi |
||||
RNAseq scRNA |
Human | Skin | Topical treatment of skin biopsies with vehicle or VTAMA (1% Tapinarof) for 5 days |
7 patients | NA | no | Oliver Steck | ||
| RNAseq | Human | T cells | T-cell clones were sampled before activation and 2, 4, 6, 9, 12, 24, and 48 hours after activation |
67 | T cell subset activated via T cell receptor | Oliver Steck | |||
| scRNA | Human | PBMC | PBMCs incubated with rIL-18 for 16h, from healthy donors and atopic dermatitis patients |
3+3 | NA | no | Nicole Bertschi | ||
| RNAseq | Human | T cells | Naïve T cells primed for 7 days in Th1 (IL-12), Th2 (IL-4), Th9 (IL-4+TGF-β), and iTreg (TGF-β) |
12 | Nicole Bertschi |
